Incyte (INCY) Enterprise Value (2009 - 2026)
Incyte's Enterprise Value came in at $20.9 billion for Q3 2026, up 52.5% from $13.7 billion a year earlier and up 14.5% from the prior quarter.
Powered by 
Analysis
Incyte (INCY) Enterprise Value (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, Incyte reported Enterprise Value of $8.77 billion, up 30.6% year-over-year; for FY2025, it was $16.02 billion, up 43.0% from FY2024.
- Enterprise Value carries a five-year compound annual growth rate of -1.5% (FY2020 to FY2025).
- Going back by year, Enterprise Value was $11.2 billion in FY2024 (+7.4%), $10.43 billion in FY2023 (-28.8%), $14.65 billion in FY2022 (+5.6%) and $13.88 billion in FY2021 (-19.7%).
- The Q3 2026 figure represents the highest quarterly Enterprise Value since Q2 2020.
- Year-over-year, Enterprise Value has increased for nine consecutive quarters, with growth averaging 33.3% over the last eight quarters.
- The fastest year-over-year change in Enterprise Value over five years came in Q2 2026 (growth of 69.0%), and the weakest in Q1 2024 (a decline of 31.3%).
- Business Quant data shows INCY's Enterprise Value at $18.25 billion (Q2 2026), $14.8 billion (Q1 2026) and $16.02 billion (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Incyte | 245.42 Mn | -15.74 Bn | 1.45 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -3.61 Bn |
| Jun 30, 2026 | -4.31 Bn |
| Mar 31, 2026 | -3.83 Bn |
| Dec 31, 2025 | -3.38 Bn |
| Sep 30, 2025 | -2.76 Bn |
| Jun 30, 2025 | -2.29 Bn |
| Mar 31, 2025 | -2.29 Bn |
| Dec 31, 2024 | -2.02 Bn |
| Sep 30, 2024 | -1.64 Bn |
| Jun 30, 2024 | -1.33 Bn |
| Mar 31, 2024 | -3.72 Bn |
| Dec 31, 2023 | -3.52 Bn |
| Sep 30, 2023 | -3.39 Bn |
| Jun 30, 2023 | -3.28 Bn |
| Mar 31, 2023 | -2.95 Bn |
| Dec 31, 2022 | -3.06 Bn |
| Sep 30, 2022 | -2.83 Bn |
| Jun 30, 2022 | -2.55 Bn |
| Mar 31, 2022 | -2.37 Bn |
| Dec 31, 2021 | -2.19 Bn |
API Access
Incyte Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=INCY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "INCY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=INCY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();